相关实验视频

Updated: Jan 13, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

血小板电流图和互白素-6预测了A型大动脉剖析患者下降大动脉的术后负面重塑

Qingsong Wu^1,2, Yue Shen^1,2, Xinfan Lin²

¹Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, China.

Journal of thoracic disease

|October 29, 2025

概括

血栓形成显微镜 (TEG) 和IL-6 (IL-6) 可以预测A型大动脉解剖 (AAD) 手术后的负重塑 (NR). 这些标志物有助于识别患有并发症风险较高的患者,改善术后管理策略.

科学领域:

心血管外科心血管外科
血液学血液学血液学
生物标志物发现发现

背景情况:

负重塑 (NR) 是A型大动脉剖析 (AAD) 修复后残留大动脉剖析 (AD) 的常见并发症.
目前,在AAD患者中术后NR的预测标志物有限,需要进一步调查.
这项研究探讨了血小板结晶学 (TEG) 和白内素-6 (IL-6) 作为NR的预测因子的潜力.

研究的目的:

评估TEG和IL-6在预测AAD患者术后NR的临床实用性.
确定可靠的指标,以评估NR在残留主动脉外科手术后的风险.

主要方法:

在2020年1月至2021年12月期间,对208名患者进行了对AAD进行全动脉门置换的回顾性分析.
术后监测2年,收集临床数据,TEG参数和IL-6水平.
包括相关性和多变量回归在内的统计分析,以确定NR的预测因素.

主要成果:

与非NR组相比,NR组 (24.0%的发病率) 呈现出明显更高的IL-6水平,更长的R-时间和K-时间,以及较低的凝块角度和最大的凝块牢固度.
较高的IL-6水平,较长的R时间和K时间被确定为NR的独立风险因素.
结合TEG参数 (R-时间,K-时间) 和IL-6表明NR的高预测值 (AUC=0.878).

结论:

在AAD患者中,TEG参数和IL-6水平是术后NR在残留AD风险的有效预测指标.
这些发现表明,TEG和IL-6可以帮助对AAD患者的风险分层和管理.

关键词:

斯坦福大学的一个大动脉剖析.互白素-6 (IL-6) 是一种蛋白质.下降大动脉的负重塑下降大动脉的负重塑预测价值是一个预测值.血栓形成显微镜 (TEG)

更多相关视频

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

相关概念视频

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...